Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-016679
Filing Date
2021-02-09
Accepted
2021-02-09 16:16:46
Documents
1
Period of Report
2021-02-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm215727-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm215727-1_4seq1.xml 4 4067
  Complete submission text file 0001104659-21-016679.txt   5610
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 ATHOL STREET DOUGLAS Y8 IM1 1JA
Business Address 18 ATHOL STREET DOUGLAS Y8 IM1 1JA 441624639396
Juvenescence Ltd (Reporting) CIK: 0001724307 (see all company filings)

State of Incorp.: Y8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 21606598